Early Changes in Nutritional Status of Elderly Patients with Lung Cancer Undergoing Chemotherapy Are Positively Related with Symptoms of Depression: A Prospective Follow-Up Study

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Grønberg BH, Sundstrøm S, Kaasa S, Bremnes RM, Fløtten O, Amundsen T, Hjelde HH, von Plessen C, Jordhøy M. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer. 2010;46(12):2225–2234. doi: 10.1016/j.ejca.2010.04.009.
   PubMed Web of Science ®Google Scholar
• Wei YF, Huang WT, Liu TC, Shieh JM, Chian CF, Wu MF, Chang CC, Lin CH, Ko JC, Lin CM, et al. Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study. J Cancer. 2019;10(17):4151–4158. doi: 10.7150/jca.30507.
   PubMed Web of Science ®Google Scholar
• Iyer S, Taylor-Stokes G, Roughley A. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer. 2013;81(2):288–293. doi: 10.1016/j.lungcan.2013.03.008.
   PubMed Web of Science ®Google Scholar
• Shoji F, Miura N, Matsubara T, Akamine T, Kozuma Y, Haratake N, Takamori S, Katsura M, Takada K, Toyokawa G, et al. Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: A multicentre retrospective study. Interact Cardiovasc Thorac Surg. 2018;26(3):389–94. doi: 10.1093/icvts/ivx337.
   PubMed Web of Science ®Google Scholar
• Kim JW, Kim YJ, Lee KW, Chang H, Lee JO, Kim KI, Bang SM, Lee JS, Kim CH, Kim JH. The early discontinuation of palliative chemotherapy in older patients with cancer. Support Care Cancer. 2014;22(3):773–781. doi: 10.1007/s00520-013-2033-y.
   PubMed Web of Science ®Google Scholar
• Liu J, Ma Y, Gao R, Liu X, Wang Y, Yu J, Zhan J, Huang Y, Qin H, Zhang L. Prognostic effects of health-related quality of life at baseline and early change in health-related quality of life on response to treatment and survival in patients with advanced lung cancer: A prospective observational study in China. BMJ Open. 2022;12(2):e047611. doi: 10.1136/bmjopen-2020-047611.
   PubMed Web of Science ®Google Scholar
• Sullivan DR, Forsberg CW, Ganzini L, Au DH, Gould MK, Provenzale D, Slatore CG. Longitudinal changes in depression symptoms and survival among patients with lung cancer: A National Cohort Assessment. J Clin Oncol. 2016;34(33):3984–3991. doi: 10.1200/JCO.2016.66.8459.
   PubMed Web of Science ®Google Scholar
• Chabowski J, Polański J, Jankowska-Polańska B, Janczak D, Rosińczuk J. Is nutritional status associated with level of anxiety, depression and pain in patients with lung cancer? J Thorac Dis. 2018;10(4):2303–2310. doi: 10.21037/jtd.2018.03.108.
   PubMed Web of Science ®Google Scholar
• Chen J, Li W, Cui L, Qian Y, Zhu Y, Gu H, Chen G, Shen Y, Liu Y. Chemotherapeutic response and prognosis among lung cancer patients with and without depression. J Cancer. 2015;6(11):1121–9. doi: 10.7150/jca.11239.
   PubMed Web of Science ®Google Scholar
• Hansen JM, Kjaer TK, Mellemgård A, Stensøe Oksen M, Andersen I, Oksbjerg Dalton S. Association between anxiety and depression symptoms and completion of first-line treatment in newly diagnosed lung cancer patients. Acta Oncol. 2023;62(7):820–824. doi: 10.1080/0284186X.2023.2207745.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Hu CH, Li YZ, Zhou JS, Wang SX, Liu MD, Qiu ZH, Deng C, Ma F, Xia CF, et al. Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer. Nat Med. 2024;30(6):1680–1688. doi: 10.1038/s41591-024-02929-4.
   PubMedGoogle Scholar
• Arrieta O, Angulo LP, Núñez-Valencia C, Dorantes-Gallareta Y, Macedo EO, Martínez-López D, Alvarado S, Corona-Cruz J-F, Oñate-Ocaña LF. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 2013;20(6):1941–1948. doi: 10.1245/s10434-012-2793-5.
   PubMed Web of Science ®Google Scholar
• de Mol M, Visser S, Aerts J, Lodder P, van Walree N, Belderbos H, den Oudsten B. The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: An observational multi-center cohort study. BMC Cancer. 2020;20(1):431. doi: 10.1186/s12885-020-06823-3.
   PubMed Web of Science ®Google Scholar
• Martucci RB, Barbosa MV, D’Almeida CA, Rodrigues VD, Bergmann A, de Pinho NB, Thuler LCS. Undernutrition as independent predictor of early mortality in elderly cancer patients. Nutrition. 2017;34:65–70. doi: 10.1016/j.nut.2016.09.011.
   PubMed Web of Science ®Google Scholar
• Ge T, Lin T, Yang J, Wang M. Nutritional status and related factors of patients with advanced lung cancer in northern China: A retrospective study. Cancer Manag Res. 2019;11:2225–2231. doi: 10.2147/CMAR.S193567.
   PubMed Web of Science ®Google Scholar
• Polański J, Dudek K, Mazur G, Chabowski M. Effect of nutritional status on psychological functioning and coping in patients with lung cancer. Nutrition. 2023;109:111970. doi: 10.1016/j.nut.2022.111970.
   PubMed Web of Science ®Google Scholar
• Degens JHRJ, Sanders KJC, de Jong EEC, Groen HJM, Smit EF, Aerts JG, Schols AMWJ, Dingemans AMC. The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer. Lung Cancer. 2019;133:130–135. doi: 10.1016/j.lungcan.2019.05.021.
   PubMed Web of Science ®Google Scholar
• Dotan E, Tew WP, Mohile SG, Ma H, Kim H, Sun CL, Caan B, Dale W, Gajra A, Klepin HD, et al. Associations between nutritional factors and chemotherapy toxicity in older adults with solid tumors. Cancer. 2020;126(8):1708–1716. doi: 10.1002/cncr.32718.
   PubMed Web of Science ®Google Scholar
• Roch B, Coffy A, Jean-Baptiste S, Palaysi E, Daures JP, Pujol JL, Bommart S. Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors. Lung Cancer. 2022;143:19–26. doi: 10.1016/j.lungcan.2020.03.003.
   Web of Science ®Google Scholar
• Giannousi Z, Gioulbasanis I, Pallis AG, Xyrafas A, Dalliani D, Kalbakis K, Papadopoulos V, Mavroudis D, Georgoulias V, Papandreou CN. Nutritional status, acute phase response and depression in metastatic lung cancer patients: Correlations and association prognosis. Support Care Cancer. 2012;20(8):1823–1829. doi: 10.1007/s00520-011-1282-x.
   PubMed Web of Science ®Google Scholar
• Xue D, Li N, Li L, Huang Y, Men K, Meng Q, Zhang S. Sarcopenia is an independent risk factor for depression in patients with advanced lung cancer. Support Care Cancer. 2022;30(11):9659–9665. doi: 10.1007/s00520-022-07384-w.
   PubMed Web of Science ®Google Scholar
• Polański J, Jankowska-Polańska B, Mazur G. Relationship between nutritional status and quality of life in patients with lung cancer. Cancer Manag Res. 2021;13:1407–1416. doi: 10.2147/CMAR.S287551.
   PubMed Web of Science ®Google Scholar
• Ruiter R, Burggraaf J, Rissmann R. Under‐representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database. Br J Clin Pharmacol. 2019;85(4):838–844. doi: 10.1111/bcp.13876.
   PubMed Web of Science ®Google Scholar
• Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, Nicholson AG, Groome P, Mitchell A, Bolejack V, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions. The IASLC lung cancer staging projects: Proposals for revision of the TNM stage groupings in the forthcoming (eight) edition of the TNM classification for lung. J Thorac Oncol. 2016;11(1):39–51. doi: 10.1016/j.jtho.2015.09.009.
   PubMed Web of Science ®Google Scholar
• Colinet B, Jacot W, Bertrand D, Lacombe S, Bozonnat M-C, Daurès J-P, Pujol J-L, oncoLR health network A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: Description and comparison with the Charlson’s index. Br J Cancer. 2005;93(10):1098–1105. doi: 10.1038/sj.bjc.6602836.
   PubMed Web of Science ®Google Scholar
• Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the FACT-L quality of life instrument. Lung Cancer. 1995;12(3):199–220. doi: 10.1016/0169-5002(95)00450-f.
   PubMed Web of Science ®Google Scholar
• Löwe B, Kroenke K, Herzog W, Gräfe K. Measuring depression outcome with a brief self-report instrument: Sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81(1):61–66. doi: 10.1016/S0165-0327(03)00198-8.
   PubMed Web of Science ®Google Scholar
• Gouliaev A, Hilberg O, Christensen NL, Rasmussen T, Ibsen R, Løkke A. Comorbidity among Danish lung cancer patients before and after initial cancer diagnosis. Eur Clin Respir J. 2021;8(1):1861579. doi: 10.1080/20018525.2020.1861579.
   Web of Science ®Google Scholar
• Krzakowski M, Jassem J, Antczak A, Chorostowska-Wynimko J, Dziaduszko R, Głogowski M, Grodzki T, Kowalski D, Olszewski W, Orłowski T, et al. Cancer of the lung, pleura and mediastinum. Oncol Clin Pract. 2019;15(1):20–50. doi: 10.5603/OCP.2018.0056.
   Web of Science ®Google Scholar
• Iyer S, Roughley A, Rider A, Taylor-Stokes G. The symptom burden of non-small cell lung cancer in the USA: A real-world cross-sectional study. Support Care Cancer. 2014;22(1):181–187. doi: 10.1007/s00520-013-1959-4.
   PubMed Web of Science ®Google Scholar
• von Plessen C, Bergman B, Andresen O, Bremnes RM, Sundstrom S, Gilleryd M, Stephens R, Vilsvik J, Aasebo U, Sorenson S. Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer. Br J Cancer. 2006;95(8):966–973. doi: 10.1038/sj.bjc.6603383.
   PubMed Web of Science ®Google Scholar
• Biesma B, Wymenga ANM, Vincent A, Dalesio O, Smit HJM, Stigt JA, Smit EF, van Felius CL, van Putten JWG, Slaets JPJ, et al. Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatyin-paclitaxel: NVALT-3 a phase III study. Ann Oncol. 2011;22(7):1520–1527. doi: 10.1093/annonc/mdq637.
   PubMed Web of Science ®Google Scholar
• Mohan A, Singh P, Kumar S, Mohan C, Pathak AK, Pandey RM, Guleria R. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer. Asian Pac J Cancer Prev. 2008;9(4):557–562.
   PubMedGoogle Scholar
• Des Guetz G, Uzzan B, Nicolas P, Valeyre D, Sebbane G, Morere J-F. Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis. Crit Rev Oncol Hematol. 2012;84(3):340–349. doi: 10.1016/j.critrevonc.2012.03.007.
   PubMed Web of Science ®Google Scholar
• Randén M, Helde-Frankling M, Runesdotter S, Strang P. Treatment decisions and discontinuation of palliative chemotherapy near the end-of-life, in relation to socioeconomic variables. Acta Oncol. 2013;52(6):1062–1066. 10.3109/0284186X.2012.758872
   PubMed Web of Science ®Google Scholar
• Extermann M, Albrand G, Chen H, Zanetta S, Schonwetter R, Zulian GB, Cantor A, Droz JP. Are older French patients as willing as older American patients to undertake chemotherapy? J Clin Oncol. 2003;21(17):3214–3219. doi: 10.1200/JCO.2003.08.091.
   PubMed Web of Science ®Google Scholar
• Morrison EJ, Novotny PJ, Sloan JA, Yang P, Patten CA, Ruddy KJ, Clark MM. Emotional problems, quality of life, and symptom burden in patients with lung cancer. Clin Lung Cancer. 2017;18(5):497–503. doi: 10.1016/j.cllc.2017.02.008.
   PubMed Web of Science ®Google Scholar
• Nipp RD, Fuchs G, El-Jawahri A, Mario J, Troschel FM, Greer JA, Gallagher ER, Jackson VA, Kambadakone A, Hong TS, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist. 2018;23(1):97–104. doi: 10.1634/theoncologist.2017-0255.
   PubMed Web of Science ®Google Scholar
• Illman J, Corringham R, Robinson D, Davis HM, Rossi JF, Cella D, Trikha M. Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol. 2005;3(1):37–50.
   PubMedGoogle Scholar
• McFarland DC, Breitbart W, Miller AH, Nelson C. Depression and inflammation in patients with lung cancer: A comparative analysis of acute phase reactant inflammatory markers. Psychosomatics. 2020;61(5):527–537. 10.1016/j.psym.2020.03.005
   PubMed Web of Science ®Google Scholar
• Zhang X, Edwards BJ. Malnutrition in older adults with cancer. Curr Oncol Rep. 2019;21(9):80. doi: 10.1007/s11912-019-0829-8.
   PubMed Web of Science ®Google Scholar
• Sánchez-Torralvo FJ, Contreras-Bolívar V, Ruiz-Vico M, Abuín-Fernández J, González-Almendros I, Barrios M, Olveira G. Relationship between malnutrition and the presence of symptoms of anxiety and depression in hospitalized cancer patients. Support Care Cancer. 2022;30(2):1607–1613. doi: 10.1007/s00520-021-06532-y.
   PubMed Web of Science ®Google Scholar
• Nucci D, Gianfredi V, Ferrara P, Santangelo OE, Varotto B, Feltrin A, Galiano A, Nardi M. Association between malnutrition and depression in patients with cancer: The importance of nutritional status evaluation in cancer care. IJERPH. 2023;20(3):2295. doi: 10.3390/ijerph20032295.
   Google Scholar